Back

Impact of substrate modification and shift in recurrence pattern in elderly patients with persistent atrial fibrillation: a sub-analysis of the SUPPRESS-AF trial

29 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Atrial substrate and atrial fibrillation outcomes Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Takashi Kanda

Osaka Keisatsu Hospital, Osaka (Japan)

6 More presentations in this session

Presentation thumbnail
BMI-dependent sex differences in atrial tachyarrhythmia recurrence despite greater low-voltage substrate in women: a SUPPRESS-AF subgroup analysis
Doctor N. Tanaka (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Right atrial structural remodeling outweighs frequency-defined drivers in persistent atrial fibrillation: the multicenter randomized PAD-AF trial
Doctor K. Matsuda (Sendai, JP)
Abstract Slides Video
Presentation thumbnail
ALDAS score for low-voltage area burden identifies differential benefit of low-voltage-guided ablation in persistent atrial fibrillation: insights from the SUPPRESS-AF trial
Doctor A. Sunaga (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Atrial substrate burden determines mitral regurgitation improvement after low-voltage area ablation: a post-hoc analysis of the SUPPRESS-AF randomized trial
Doctor A. Sugino (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Impact of the right atrial substrate on arrhythmia recurrence following atrial fibrillation ablation
Doctor N. Bodagh (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial substrate and atrial fibrillation outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
SUPPRESS-AF - The efficacy of low-voltage-area ablation on atrial tachyarrhythmias recurrence in patients with persistent atrial fibrillation
2 September 2024
thumbnail
Congress Presentation
Ablation efficacy and safety in elderly vs. super-elderly with atrial fibrillation: insights from the prospective multicenter REAL-AF registry
30 August 2026
thumbnail
Congress Presentation
Combined impact of diagnosis-to-ablation time and left atrial volume on one-year recurrence after first pulmonary vein isolation
28 August 2026
thumbnail
Congress Presentation
Persistent atrial fibrillation: what lies beyond pulmonary vein isolation?
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources